Flexible RSV prefusogenic fusion glycoprotein exposes multiple neutralizing epitopes that may collectively contribute to protective immunityNita Patel(Novavax (United States)), Gale Smith(Novavax (United States))bioRxiv (Cold Spring Harbor Laboratory)September 14, 202010.1101/2020.09.14.296350Cited by 10SaveCiteExport RISWatch citationsRelated PapersSARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice|Nature Communications|2021|524Flexible RSV Prefusogenic Fusion Glycoprotein Exposes Multiple Neutralizing Epitopes that May Collectively Contribute to Protective Immunity|Vaccines|2020|22